Hepion Pharmaceuticals Inc [NASDAQ: HEPA] stock went on an upward path that rose over 12.82% on Tuesday, amounting to a one-week price decrease of less than -31.98%.
Over the last 12 months, HEPA stock dropped by -99.61%. The one-year Hepion Pharmaceuticals Inc stock forecast points to a potential upside of 99.96. The average equity rating for HEPA stock is currently 3.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $0.52 million, with 1.08 million shares outstanding and 1.07 million shares in the current float. Compared to the average trading volume of 1.12M shares, HEPA stock reached a trading volume of 50555453 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Hepion Pharmaceuticals Inc [HEPA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HEPA shares is $1100.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HEPA stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH Capital have made an estimate for Hepion Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 20, 2020.
HEPA Stock Performance Analysis:
Hepion Pharmaceuticals Inc [HEPA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -31.98. With this latest performance, HEPA shares dropped by -91.40% in over the last four-week period, additionally sinking by -98.57% over the last 6 months – not to mention a drop of -99.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HEPA stock in for the last two-week period is set at 20.55, with the RSI for the last a single of trading hit 15.12, and the three-weeks RSI is set at 25.41 for Hepion Pharmaceuticals Inc [HEPA]. The present Moving Average for the last 50 days of trading for this stock 5.9254, while it was recorded at 0.5380 for the last single week of trading, and 28.5216 for the last 200 days.
Insight into Hepion Pharmaceuticals Inc Fundamentals:
Hepion Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.
Hepion Pharmaceuticals Inc [HEPA] Institutonal Ownership Details
There are presently around $1.48%, or 1.51%% of HEPA stock, in the hands of institutional investors.
